| Dr Serena Wong, DO | |
|
40 Duke Medicine Cir Rm 2512, Durham, NC 27710-2527 | |
| (919) 660-7562 | |
| Not Available |
| Full Name | Dr Serena Wong |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 40 Duke Medicine Cir Rm 2512, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710306204 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 228367 (North Carolina) | Primary |
| 208D00000X | General Practice | 228367 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke Regional Hospital | Durham, NC | Hospital |
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Duke University Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
Catalyst Pharmaceutical Partners, Inc. has announced top-line results from its U.S. Phase II clinical trial to treat cocaine addiction.
Language used in everyday social media posts may have a strong connection to an individual's health, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.
› Verified 3 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Catalyst Pharmaceutical Partners, Inc. has announced top-line results from its U.S. Phase II clinical trial to treat cocaine addiction.
Language used in everyday social media posts may have a strong connection to an individual's health, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.
› Verified 3 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Catalyst Pharmaceutical Partners, Inc. has announced top-line results from its U.S. Phase II clinical trial to treat cocaine addiction.
Language used in everyday social media posts may have a strong connection to an individual's health, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Serena Wong, DO 40 Duke Medicine Cir Rm 2502, Durham, NC 27710-4000 Ph: (919) 660-7568 | Dr Serena Wong, DO 40 Duke Medicine Cir Rm 2512, Durham, NC 27710-2527 Ph: (919) 660-7562 |
News Archive
Catalyst Pharmaceutical Partners, Inc. has announced top-line results from its U.S. Phase II clinical trial to treat cocaine addiction.
Language used in everyday social media posts may have a strong connection to an individual's health, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.
› Verified 3 days ago
Dr. Stephen John Greene, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd # Dumc3845, Durham, NC 27705 Phone: 919-684-8111 | |
Dr. Jacob Paul Feigal, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: Duke University Hospital Gme, Box 3951, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. David Keith Bright, MD, PHARM D Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4205 Ben Franklin Blvd, Durham, NC 27704 Phone: 919-477-6900 Fax: 919-477-5081 | |
Yuri Anthony Fesko, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 4101 N Roxboro St, Durham, NC 27704 Phone: 919-684-8111 | |
Mary E Klotman, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 | |
Jonathan Paul Piccini Sr., M.D., M.H.S. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. Deborah Anne Fisher, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 508 Fulton St, Durham, NC 27705 Phone: 919-286-6945 |